U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265609) titled 'Clinical Performance of Two Different Resin-Matrix Ceramic Restorations' on Nov. 17. Brief ... Read More
U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07267858) titled 'Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach.' o... Read More
Tokyo, Dec. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059992) titled 'Investigation of the relaxing effects of functional aromatic components' on ... Read More
Tokyo, Dec. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059894) titled 'Effects of an Eight-Week Functional Hopping Program on Pain, Strength, and P... Read More
Tokyo, Dec. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059958) titled 'A Scoping Review of Rehabilitation for Speech Disorders after Oral Cancer S... Read More
Tokyo, Dec. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059973) titled 'Immediate Effects of Thoracic Extension Exercise on Pectoralis Minor Stiffne... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263919) titled 'Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Sq... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264140) titled 'Assessing and Improving Misuse of Inhalers in COPD Outpatients' on Nov. 24. Brief Summary: ... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07262840) titled 'Health Behavior Change in High-Risk Colorectal Cancer Individuals' on Nov. 19. Brief Summar... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264517) titled 'Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye ... Read More